Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...
County Public Schools has joined dozens of other school systems and institutions in suing pharmaceutical and pharmacy companies, alleging that the companies manipulated the prices of insulin and other ...
Earlier this month, non-profit drugmaker Civica Rx pledged to launch biosimilars of three big-selling insulin products in the US – Sanofi's Lantus, Novo Nordisk's Novolog and Eli Lilly's Humalog ...
UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00. The company’s ...
Products under the program include insulin vials, pens, continuous glucose monitors and pumps by manufacturers Novo Nordisk, Eli Lilly, Sanofi, Dexcom and Insulet. About one in 10 Americans have ...
Last year, non-profit drugmaker Civica Rx pledged to launch biosimilars of three big-selling insulin products in the US – Sanofi's Lantus, Novo Nordisk's Novolog, and Lilly's Humalog – by 2024.
Kepler Capital analyst David Evans maintained a Hold rating on Novo Nordisk (0QIU – Research Report) on January 13 and set a price target of ...
North Dakota lawmakers on Thursday will hear testimony on a bill to lower the price of insulin drugs and supplies for ...